http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2566723-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73b2f2222c40bad5ead9c6d544478def http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_511f6422bd60c264b64e83866b0736ec |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2014-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f32a111e6f0a9f13a2656f2dfc231ded http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1efcdbc89e240b39e94b003ef5e65de8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_894e909d26e8f7f4dc2820060b678568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e524e9f5f9d4217b8736656bf7f5f80b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48a139b894c2aeb4d0a26a393272050e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e081e74507a7aac9327a6347b37d6119 |
| publicationDate | 2015-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2566723-C2 |
| titleOfInvention | Method of differential diagnostics of autoimmune liver diseases |
| abstract | FIELD: medicine. n SUBSTANCE: invention is intended for differential diagnostics of various nosological forms of autoimmune liver diseases (AILD). To carry out differential diagnostics of autoimmune liver diseases clinical-and-laboratory, morphological and immunomorphologcal tests with immunhistochemical determination of bcl-2 in liver tissue are performed. Comparative analysis of content of bcl-2 positive cells is carried out and the level of percent content of bcl-2 is determined. Differential diagnostics is carried out between primary biliary cirrhosis if value is 66%-100% and cross syndrome - autoimmune hepatitis/primary biliary cirrhosis - lower than 66%; between autoimmune hepatitis - 33%-66% and primary biliary cirrhosis - 66%-100%; between autoimmune hepatitis 33%-66% and chronic viral hepatitis C - 0%-33%. n EFFECT: application of invention makes it possible to increase reliability of differential diagnostics of cross syndromes of autoimmune liver diseases, with further optimisation of therapy, depending on stated diagnosis. n 1 dwg, 1 tbl, 3 ex |
| priorityDate | 2014-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.